BioSpace News Archive

Gemina Laboratories Ltd. is pleased to announce that its inaugural product - the Gemina Legio XTM COVID-19 Rapid Antigen Test - has been awarded an EU CE Mark under the EU’s In Vitro Diagnostic Medical Device Directive.

HealthTech Arkansas and MedAxiom have come together to create HeartX, a cardiovascular-focused healthcare accelerator, to facilitate guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market.

Journal of Endovascular Therapy, 2022 with title “Stents with torsional strength for Superficial Femoral artery disease.

Kibow Pharmaceuticals LLC is a phase 2/3 clinical-stage company focused on developing novel live biotherapeutic products (LBP) for chronic kidney disease (CKD) patients.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that it has received clearance from the FDA for its investigational new drug application (IND) for Abivertinib (Fujovee™) for the Phase 2 MAVERICK study to be conducted in participants with metastatic castrate resistant prostate cancer (mCRPC) at multiple centers in the United States.

Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options, announced the appointment of Ryan S. Bleeks as Chief Executive Officer.

Vivera Biosciences is pleased to announce its collaborative progress on a Cooperative Research and Development Agreement with the National Institute of Neurological Disorders and Stroke, an Institute within the National Institutes of Health that aims to foster and advance cutting-edge neuroscience research to reduce the burden of neurological disease.

Virax Biolabs Group Limited, an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, is pleased to announce the formation of its initial Board of Directors.

The Celiac Disease Foundation is pleased to announce the establishment of two international celiac disease research prizes.

LabConnect, Inc. is pleased to announce the appointment of Ms. Dawn Sherman to serve as its Chief Executive Officer and member of the Board of Directors.